Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Non-invasive Imaging of Cetuximab-Zr. 89 Uptake Wit PET: a Phase I Trial in Stage IV Cancer Patients (Cetuximab Zr89)

This study has been completed.
VU University Medical Center
Information provided by (Responsible Party):
Maastricht Radiation Oncology Identifier:
First received: June 2, 2008
Last updated: April 9, 2015
Last verified: April 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2015
  Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)